Login to Your Account



Pharma: Other News To Note


Thursday, July 5, 2012
• Mundipharma International Ltd., of Cambridge, UK, said the European Commission approved combination therapy flutiform (fluticasone propionate/formoterol fumarate) for the maintenance treatment of asthma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription